Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer - Denis, F; Desbiez-Bourcier, A V; Chapiron, C; Arbion, F; Body, G; Brunereau, L (Eur J Surg Oncol, 2004)